EZR and colorectal carcinoma: Further, our results demonstrate that km23-1 may be a novel anti-metastatic target for CRC, showing for the first time that km23-1 regulates constitutive ERK activation, the pro-migratory effects of high Ezrin expression, TGFβ1 production, and the paracrine effects of CRC cell-secreted factors.